02Jan 2024
Dupilumab Shows Promise in Alleviating Key Symptoms of Chronic Rhinosinusitis with Nasal Polyps

Dupilumab Shows Promise in Alleviating Key Symptoms of Chronic Rhinosinusitis with Nasal Polyps

A post hoc analysis of SINUS-24 and SINUS-52 trials aimed to evaluate the severity of the top 5 22-item Sino-Nasal Outcome Test (SNOT-22) items, prioritized by chronic rhinosinusitis with nasal polyps (CRSwNP) patients. The study revealed that a "decreased sense of smell/taste" was the most crucial symptom for 87% of patients. Dupilumab demonstrated significant improvement in severity scores for the top 5 items, aligning with enhanced objective disease measures and providing valuable insights for CRSwNP management.

  • #ent

Like

Save

Share